Comparing Risk Factors for Past 30-day E-cigarette and Combustible Tobacco Use: a Longitudinal analysis of the Texas adolescent Tobacco and Marketing Surveillance Study (2014-2017).
Individual Clinical
Safety
Adverse Effects
Obinwa (2021)
association Between e-Cigarette Use and Depression in the Behavioral Risk Factor Surveillance System, 2016-2017.
Individual Clinical
Safety
Adverse Effects
Obisesan (2019)
association between electronic cigarette use and tobacco cigarette smoking initiation in adolescents: a systematic review and meta-analysis.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
O'Brien (2021)
a randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic profiles of cigarettes and e-cigarettes with nicotine salt formulations in US adult smokers.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
O'Connell (2019)
Characteristics of nicotine vaping products used by participants in the 2016 ITC Four Country Smoking and Vaping Survey.
Individual Clinical
User Topography
O'Conner (2019)
E-Cigarette Use and Subsequent Cigarette Initiation and Sustained Use among Youth, U.S., 2015-2017.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Odani (2020)
Vaping and psychotic experiences among college students in the United States.
Individual Clinical
Safety
Adverse Effects
Oh (2021)
Binary classification of users of electronic cigarettes and smokeless tobacco through biomarkers to assess similarity with current and former smokers: machine learning applied to the population assessment of tobacco and health study.
Individual Clinical
Biomarkers
Biomakers Of Exposure
Ohara (2023)
association between electronic cigarette and combustible cigarette use with cardiometabolic risk biomarkers among U.S. adults.
Individual Clinical
Biomarkers
Biomakers Of Harm
Okafor (2022)
Particle size distribution of selected electronic nicotine delivery system products
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Oldham (2018)